Characteristics and outcome of radiation and chemotherapy‐related mucoepidermoid carcinoma of the salivary glands
- 28 January 2011
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 57 (7) , 1137-1141
Abstract
Background Mucoepidermoid carcinoma (MEC) of the salivary glands has been reported to occur in patients previously treated with chemotherapy and/or radiation. The purpose of our study is to review the patient, tumor, and treatment characteristics of patients who develop a treatment-related MEC. Procedure A PubMed search of English language articles was performed using the keywords and MeSH terms: mucoepidermoid, salivary gland, radiation-induced, second malignancy, radiotherapy, and chemotherapy. Results The search yielded 23 articles describing 58 patients who received chemotherapy and/or radiotherapy (RT) and subsequently developed MEC. The most common initial diagnoses were acute lymphoblastic leukemia (n = 18), acne (n = 9), and Hodgkin lymphoma (n = 6). Patients were divided into three groups according to chemotherapy and RT treatment: chemotherapy alone (n = 14), RT alone (n = 14), or chemotherapy and RT (n = 30). The parotid gland was the most common site for secondary MEC. Latent time (LT) to development of MEC from initial tumor treatment was significantly shorter in the patients treated with chemotherapy ± RT versus RT alone (7.9 years vs. 27.2 years, P < 0.01). The most common treatment for MEC was surgery alone followed by surgery and postoperative RT. The 2- and 5-year overall survival rates were 98% and 93.4% while the 2- and 5-year locoregional control rates were 97.7% and 92.5%, respectively. There was no difference in survival or locoregional control between groups exposed to RT alone, chemotherapy alone, or chemotherapy with RT for the initial tumor. Conclusion Radiation and chemotherapy-related MEC has an excellent prognosis. Pediatr Blood Cancer 2011; 57: 1137–1141.Keywords
This publication has 37 references indexed in Scilit:
- Do Radiation-Associated Soft Tissue Sarcomas Have the Same Prognosis As Sporadic Soft Tissue Sarcomas?Journal of Clinical Oncology, 2010
- Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinomaCancer, 2008
- Radiation-associated endometrial cancers are prognostically unfavorable tumors: A clinicopathologic comparison with 527 sporadic endometrial cancersGynecologic Oncology, 2006
- Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasmsHead & Neck, 2006
- Secondary parotid mucoepidermoid carcinoma after TBI and chemotherapy in childhood AMLPediatric Blood & Cancer, 2006
- Mucoepidermoid carcinoma of the parotid gland as a second malignant neoplasmPediatric Blood & Cancer, 2004
- Second malignant neoplasms in long‐term survivors of osteosarcomaCancer, 2002
- PAROTID MUCOEPIDERMOID CARCINOMA FOLLOWING CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAPediatric Hematology and Oncology, 2001
- A case report of mucoepidermoid carcinoma of the parotid gland developing after radioiodine therapy for thyroid carcinomaEuropean Journal of Surgical Oncology, 1995
- Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's LymphomaJNCI: Journal of the National Cancer Institute, 1995